Redden P R, Melanson R L, Douglas J A, Dick A J
Scotia Research Institute, P.O. Box 818, Kentville, NS, B4N 4H8, Canada.
Int J Pharm. 1999 Apr 15;180(2):151-60. doi: 10.1016/s0378-5173(98)00372-x.
A series of acyloxymethyl drug derivatives of the NH-acidic drugs, phenytoin and theophylline and of the carboxylic acid drugs, thioctic acid and indomethacin, were prepared in order to determine the effect of varying the nature of the drug on the in vitro rate of hydrolysis catalyzed by porcine liver esterase and human plasma. The acyl portion was comprised of either valeric acid (val) or gamma-linolenic acid (GLA). With the exception of some GLA prodrugs, the derivatives displayed first-order kinetics in both enzyme systems. The NH-acidic drug derivatives were hydrolyzed faster than the carboxylic drug derivatives by porcine liver esterase and human plasma. It was found that the short chain valeric acid derivatives were hydrolyzed faster than the GLA derivatives. The rates of hydrolysis for the relatively smaller prodrugs of theophylline and thioctic acid were greater than the rates of hydrolysis for the bulkier phenytoin and indomethacin prodrugs indicating steric hindrance was important. The lipophilicity index, log K, of the valeric acid drug derivatives was plotted against the logarithm of the hydrolysis rate constant, k, and it was observed that log k decreased with an increase in log K. A comparison of these results with those of previous studies where the alkyl and acyl moieties were varied of acyloxyalkyl theophylline derivatives has provided a rationale, based on lipophilicity, for the structure of a prodrug to be designed based on an in vitro desired rate of hydrolysis.
制备了一系列NH-酸性药物(苯妥英和茶碱)以及羧酸药物(硫辛酸和吲哚美辛)的酰氧基甲基药物衍生物,以确定改变药物性质对猪肝酯酶和人血浆催化的体外水解速率的影响。酰基部分由戊酸(val)或γ-亚麻酸(GLA)组成。除了一些GLA前药外,这些衍生物在两种酶系统中均表现出一级动力学。NH-酸性药物衍生物在猪肝酯酶和人血浆中的水解速度比羧酸药物衍生物快。发现短链戊酸衍生物的水解速度比GLA衍生物快。茶碱和硫辛酸相对较小的前药的水解速率大于体积较大的苯妥英和吲哚美辛前药的水解速率,这表明空间位阻很重要。将戊酸药物衍生物的亲脂性指数log K与水解速率常数k的对数作图,观察到log k随着log K的增加而降低。将这些结果与先前研究的结果进行比较,在先前的研究中,酰氧基烷基茶碱衍生物的烷基和酰基部分有所变化,这基于亲脂性为根据体外所需水解速率设计前药的结构提供了理论依据。